Anti-SARS CoV-2-Spike [4E-1G]

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

• Name: Anti-SARS CoV-2-Spike [4E-1G]
• Research fields: Microbiology
• Class: Monoclonal
• Conjugation: Unconjugated
• Reactivity: Virus
• Host: Mouse
• Application: ELISA ; IHC ; Fn ; WB
• Description: The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2.
• Immunogen: Recombinant SAR-CoV-2 spike-human Fc protein
• Isotype: IgG1 kappa
• Myeloma used: NS1/0
• Recommended controls: Recombinant SARS CoV-2-Spike-human Fc protein

Target Details

• Target: SARS CoV-2 Spike
• Target background: The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2.

Applications

• Application: ELISA ; IHC ; Fn ; WB

Handling

• Format: Liquid
• Concentration: 0.9-1.1mg/ml
• Unit size: 100 ug
• Storage buffer: PBS with 0.02% azide
• Storage conditions: -15° C to -25° C
• Shipping conditions: Shipping at 4° C